The impact of immortal time bias on the estimated mortality benefit of antifibrotic therapy in IPF

被引：0

作者：

Wilskow, Marit Bjorna ^{[1
]}

Diep, Phuong Phuong ^{[2
,3
]}

Hyldgaard, Charlotte ^{[4
]}

Carlson, Lisa ^{[5
]}

Kalafatis, Dimitrios ^{[5
]}

Pesonen, Ida ^{[5
]}

Skoeld, Magnus ^{[6
,7
]}

Shaker, Saher Burhan ^{[8
]}

Bendstrup, Elisabeth ^{[9
]}

Hoyer, Nils ^{[8
]}

Durheim, Michael Thomas ^{[2
,3
]}

机构：

[1] Nordland Hosp, Dept Resp Med, Bodo, Norway

[2] Oslo Univ Hosp, Dept Resp Med, Rikshosp, Oslo, Norway

[3] Univ Oslo, Inst Clin Med, Oslo, Norway

[4] Silkeborg Reg Hosp, Diag Ctr, Silkeborg, Denmark

[5] Karolinska Inst, Dept Med Solna, Resp Med Unit, Stockholm, Sweden

[6] Karolinska Univ Hosp, Dept Resp Med & Allergy, Stockholm, Sweden

[7] Karolinska Inst, Dept Med Solna, Stockholm, Sweden

[8] Herlev & Gentofte Hosp, Dept Resp Med, Copenhagen, Denmark

[9] Aarhus Univ, Ctr Rare Lung Dis, Dept Resp Dis & Allergy, Dept Clin Med,Ctr Rare Lung Dis, Aarhus, Denmark

来源：

EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷

关键词：

D O I：

10.1183/13993003.congress-2024.PA2433

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[31] Immortal time bias in estimates of mortality among infliximab-treated patients with Crohn's disease
Lewis, James D.
GUT, 2010, 59 (11) : 1586 - 1587
[32] Impact of antifibrotic therapy on lung cancer incidence and mortality in patients with idiopathic pulmonary fibrosis
Jo, Yong Suk
Kim, Kyung Joo
Rhee, Chin Kook
Kim, Yong Hyun
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[33] Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias
van der Vaart, Thomas W.
Prins, Jan M.
van Werkhoven, Cornelis H.
ten Doesschate, Thijs
Soetekouw, Robin
van Twillert, Gitte
Veenstra, Jan
Herpers, Bjorn L.
Rozemeijer, Wouter
Jansen, Rogier R.
Bonten, Marc J. M.
van der Meer, Jan T. M.
CLINICAL INFECTIOUS DISEASES, 2023, 77 (01) : 9 - 15
[34] Impact of antifibrotic therapy on lung cancer incidence and mortality in patients with idiopathic pulmonary fibrosis
Jo, Yong Suk
Kim, Kyung Joo
Rhee, Chin Kook
Kim, Yong Hyun
JOURNAL OF THORACIC DISEASE, 2024, 16 (12)
[35] Caveat for Immortal Time Bias in Adjuvant Therapy-Related Population-Based Analyses
Gill, Beant S.
Flickinger, John C.
Beriwal, Sushil
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) : 2931 - +
[36] Immortal time bias in retrospective analysis: Is there a survival benefit in patients with glioblastoma who received prolonged treatment of adjuvant valganciclovir?
Liu, Chia-Jen
Hu, Yu-Wen
INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (01) : 250 - 251
[37] Caveat for Immortal Time Bias in Adjuvant Therapy-Related Population-Based Analyses Reply
Robinson, Cliff G.
Patel, Aalok P.
DeWees, Todd
Morgensztern, Daniel
Bradley, Jeffrey D.
Puri, Varun
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) : 2932 - +
[38] Reduced Mortality With Sodium-Glucose Cotransporter-2 Inhibitors in Observational Studies Avoiding Immortal Time Bias
Suissa, Samy
CIRCULATION, 2018, 137 (14) : 1432 - 1434
[39] Mortality benefit of rescue angioplasty following fibrinolytic therapy is time dependent
Patel, VB
Hsu, CH
Robbins, MA
CIRCULATION, 1999, 100 (18) : 359 - 359
[40] Estimating the effect of immortal-time bias in urological research: a case example of testosterone-replacement therapy
Wallis, Christopher J. D.
Saskin, Refik
Narod, Steven A.
Law, Calvin
Kulkarni, Girish S.
Seth, Arun
Nam, Robert K.
BJU INTERNATIONAL, 2017, 120 (04) : 584 - 590

← 1 2 3 4 5 →